Sharwan Hudda

Sharwan Hudda

Auto-generated profile, based on publicly available information

Sharwan Hudda

School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, (Punjab), India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Current Organic Synthesis
Verified
Journal Article
Closed access
PDF file
MCManish Chaudhary
Manish Chaudhary
SSShareef Shaik
Shareef Shaik
MMMuskan Magan
Muskan Magan
SHSharwan Hudda
Sharwan Hudda
MGMukta Gupta
Mukta Gupta
PWPANKAJ WADHWA
PANKAJ WADHWA
: The [4+2] Diels-Alder cycloaddition has been widely used for the synthesis of six-member scaffolds. In recent years, there have been significant developments in this area, including the discovery and design of novel dienes and dienophiles with improved reactivity and selectivity. These new building blocks can be used to develop diverse molecular structures with functional group compatibility. Additionally, there is the use of catalytic systems and metal-mediated reactions to enable asymmetric [4+2] cycloadditions, resulting in enantiomerically enriched products. Overall, recent studies related to [4+2] Diels-Alder cycloaddition using numerous dienes, dienophiles, and catalysts in different reaction conditions have significantly improved the efficiency, selectivity, and versatility of the reaction, making it an increasingly important tool in the synthesis of complex organic molecules as presented in this review. These advancements offer exciting possibilities for the development of new methods and reagents for the construction of six-membered rings and the synthesis of bioactive compounds.

1 December 2024 in Current Organocatalysis
Verified
Journal Article
Closed access
PDF file
SHSharwan Hudda
Sharwan Hudda
PWPANKAJ WADHWA
PANKAJ WADHWA
MGMukta Gupta
Mukta Gupta
MCManish Chaudhary
Manish Chaudhary
LLLakhan Lakhujani
Lakhan Lakhujani
: TiCl4 is a widely utilized reagent in organic synthesis, often functioning through Lewis’s acid-promoted transformations. This review explores the potential for TiCl4 to catalyse various examples, adhering to the classic catalyst definition and allowing for the use of sub-stoichiometric quantities of the catalyst relative to the substrate. The use of metal catalysts in organic synthesis has witnessed a surge in interest due to their ability to facilitate a wide range of chemical reactions. This review article highlights the significance of titanium metal catalysts via comparison with other metal catalysts like Pd (NO3)2, IrO4, Au/Fe2O3, SnCl2, and AlCl3. Among these catalysts, titanium tetrachloride (TiCl4) has gained considerable popularity for its cost-effectiveness, eco-friendliness, enhancing reaction efficiency, and ability to accelerate reactions while reducing reaction times. This comparison helps in determining the most suitable catalyst for different chemical processes, considering efficiency, safety, and economic factors. TiCl4 operates as a non-consumable catalyst, allowing for the use of sub-stoichiometric quantities relative to the substrate. : This review discusses TiCl4's applications, efficiency, and mechanisms in organic synthesis. It distinguishes itself by presenting new applications and comparative efficiencies of TiCl4, delving into detailed reaction mechanisms, and discussing its environmental, economic, and safety aspects. TiCl4's role in pivotal chemical reactions, such as Friedel-Crafts acylation and alkylation, epoxidation, cyclization, Mannich reactions, Suzuki-Miyaura reactions, Pechmann condensation, Knoevenagel condensation, anti-Markovnikov hydration, pinacol coupling, and Diels-Alder reactions. These reactions have led to the synthesis of biologically active compounds like zolmitriptan, ropinirole, risperidone, and rivastigmine. TiCl4-catalyzed reactions are characterized by their mild conditions, high efficiency, and selectivity, making them an attractive choice for modern organic cyclic, acyclic, and heterocyclic synthesis.

1 August 2023 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
ASAyush Somwanshi
Ayush Somwanshi
PWPANKAJ WADHWA
PANKAJ WADHWA
ARAmir Raza
Amir Raza
SHSharwan Hudda
Sharwan Hudda
MMMuskan Magan
Muskan Magan
KKKanav Khera
Kanav Khera
Background: Due to potential toxicity, non-biodegradable polymers used in 3D (3-dimensional) printing of drugs could be dangerous for patient safety and the environment. Objective: This review aims to investigate the toxicity of non-biodegradable polymers and investigate the use of natural materials as an alternative in 3D printing medicines. The study evaluates the dangers connected to 3D printing. Methods: A review of the literature on various 3D printing processes, such as inkjet printing, fused filament manufacturing, and extrusion-related 3DP systems, was done for this study. Also, the use of cellulose derivatives and natural materials in 3D printing and their potential as active excipients was proposed. Results: The review identified potential toxicity risks linked to non-biodegradable polymers used in drug 3D printing. As a potential fix for this issue, the use of natural materials with improved mechanical and thermal properties was explored. The use of cellulose derivatives as an alternative to non-biodegradable polymers in 3D printing pharmaceuticals was also investigated in the study. Conclusion: This study emphasises the significance of evaluating the risks connected to drug 3D printing and recommends using natural materials as an alternative to non-biodegradable polymers. More study is required to create secure and reliable 3D printing processes for pharmaceuticals.